Ridaforolimus
Jump to navigation
Jump to search
| Ridaforolimus | |
|---|---|
| Term | Ridaforolimus |
| Short definition | ridaforolimus - (pronounced) (rih-duh-foh-ROH-lih-mus) A substance being studied for the treatment of soft tissue and bone cancer. It is also being studied for the treatment of other solid tumors and hematological cancers. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
ridaforolimus - (pronounced) (rih-duh-foh-ROH-lih-mus) A substance being studied for the treatment of soft tissue and bone cancer. It is also being studied for the treatment of other solid tumors and hematological cancers. Ridaforolimus stops cell division and can cause cancer cells to die. It's a type of mTOR inhibitor. Also called AP23573
External links
- Medical encyclopedia article on Ridaforolimus
- Wikipedia's article - Ridaforolimus
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski